{"id":749795,"date":"2023-04-20T16:53:34","date_gmt":"2023-04-20T20:53:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/"},"modified":"2023-04-20T16:53:34","modified_gmt":"2023-04-20T20:53:34","slug":"qiagen-announces-expansion-of-supervisory-board","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/","title":{"rendered":"QIAGEN announces expansion of Supervisory Board"},"content":{"rendered":"<h2>\nSteve Rusckowski has joined Supervisory Board and will stand for election at Annual General Meeting in June 2023<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">Venlo, the Netherlands, April  20, 2023  (GLOBE NEWSWIRE) &#8212; QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Steve Rusckowski, an internationally recognized healthcare industry executive and former Chairman, President and CEO of Quest Diagnostics, has joined the Supervisory Board as a new member and will stand for election at the next Annual General Meeting scheduled for June 22, 2023.<\/p>\n<p align=\"justify\">\u201cIt is with great pleasure that we welcome Steve Rusckowski to our Supervisory Board. He has had a remarkable career in the healthcare industry and a proven track record as the leader of one of the world\u2019s most important diagnostics companies. We are looking forward to him making many contributions to the future success of QIAGEN,\u201d said Lawrence Rosen, Chair of the Supervisory Board. \u201cWe are also looking forward to again meeting with our shareholders in person at the Annual General Meeting in June. It is an opportunity to show how QIAGEN is navigating a volatile macro environment in 2023 and executing on a strategy that positions us well for the future.\u201d<\/p>\n<p align=\"justify\">Mr. Rusckowski most recently served as Chairman, President and Chief Executive Officer of Quest Diagnostics Incorporated. He joined Quest Diagnostics as President and Chief Executive Officer in May 2012, and was named Chairman in 2016. He stepped down from his role as President and CEO in 2022, and as Chairman in early 2023. Prior to joining Quest Diagnostics, Mr. Rusckowski was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard\/Agilent Technologies. Mr. Rusckowski previously served as a member of the Board of Directors of Xerox Holdings Corporation and Covidien plc. He earned a bachelor\u2019s degree in Mechanical Engineering from Worcester Polytechnic Institute and a master\u2019s in Management from the Massachusetts Institute of Technology\u2019s Sloan School of Management.<\/p>\n<p align=\"justify\">\n        <b>About QIAGEN <\/b>\n      <\/p>\n<p align=\"justify\">QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of December\u00a031, 2022, QIAGEN employed approximately 6,200 people in over 35 locations worldwide. Further information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HLnE_8HHHM32pOzaD8sawCLTQyvXyGDP9ZUtWmmu4lWv0PwELmiiEbfX4ltZl8RP3aJEtvzBqmrqCOBLD5PbSA==\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.qiagen.com<\/a>.<\/p>\n<p align=\"justify\">\n        <b>Forward-Looking Statement <\/b>\n      <\/p>\n<p align=\"justify\">\n        <i>Certain statements contained in this press release may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements contained herein relating to QIAGEN&#8217;s products, collaborations markets, strategy or operating results, including without limitation its expected adjusted net sales and adjusted diluted earnings results, are forward-looking, such statements are based on current expectations and assumptions that involve a number of uncertainties and risks. Such uncertainties and risks include, but are not limited to, risks associated with management of growth and international operations (including the effects of currency fluctuations, regulatory processes and dependence on logistics), variability of operating results and allocations between customer classes, the commercial development of markets for our products to customers in academia, pharma, applied testing and molecular diagnostics; changing relationships with customers, suppliers and strategic partners; competition; rapid or unexpected changes in technologies; fluctuations in demand for QIAGEN&#8217;s products (including fluctuations due to general economic conditions, the level and timing of customers&#8217; funding, budgets and other factors); our ability to obtain regulatory approval of our products; difficulties in successfully adapting QIAGEN&#8217;s products to integrated solutions and producing such products; the ability of QIAGEN to identify and develop new products and to differentiate and protect our products from competitors&#8217; products; market acceptance of QIAGEN&#8217;s new products and the integration of acquired technologies and businesses. For further information, please refer to the discussions in reports that QIAGEN has filed with, or furnished to, the U.S. Securities and Exchange Commission (SEC).<\/i>\n      <\/p>\n<p>Source: QIAGEN N.V.<br \/>Category: Corporate<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZWFmZTgyZjEtOGY4Zi00NjNlLWIyMzAtYjIxMjNjZTkwYTQ1LTEwMzA5NDM=\/tiny\/QIAGEN-N-V-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>John Gilardi\r\nQIAGEN N.V.\r\n+49 2103 29 11711\r\nir@qiagen.com\r\n\r\nPhoebe Loh\r\nQIAGEN N.V.\r\n+49 2103 29 11457\r\nir@qiagen.com\r\n\r\nThomas Theuringer\r\nQIAGEN N.V.\r\n+49 2103 29 11826\r\npr@qiagen.com\r\n\r\nDaniela Eltrop\r\nQIAGEN N.V.\r\n+49 2103 29 11676\r\npr@qiagen.com\r\n<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Steve Rusckowski has joined Supervisory Board and will stand for election at Annual General Meeting in June 2023 Venlo, the Netherlands, April 20, 2023 (GLOBE NEWSWIRE) &#8212; QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Steve Rusckowski, an internationally recognized healthcare industry executive and former Chairman, President and CEO of Quest Diagnostics, has joined the Supervisory Board as a new member and will stand for election at the next Annual General Meeting scheduled for June 22, 2023. \u201cIt is with great pleasure that we welcome Steve Rusckowski to our Supervisory Board. He has had a remarkable career in the healthcare industry and a proven track record as the leader of one of the world\u2019s most important diagnostics companies. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;QIAGEN announces expansion of Supervisory Board&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749795","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>QIAGEN announces expansion of Supervisory Board - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"QIAGEN announces expansion of Supervisory Board - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Steve Rusckowski has joined Supervisory Board and will stand for election at Annual General Meeting in June 2023 Venlo, the Netherlands, April 20, 2023 (GLOBE NEWSWIRE) &#8212; QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Steve Rusckowski, an internationally recognized healthcare industry executive and former Chairman, President and CEO of Quest Diagnostics, has joined the Supervisory Board as a new member and will stand for election at the next Annual General Meeting scheduled for June 22, 2023. \u201cIt is with great pleasure that we welcome Steve Rusckowski to our Supervisory Board. He has had a remarkable career in the healthcare industry and a proven track record as the leader of one of the world\u2019s most important diagnostics companies. &hellip; Continue reading &quot;QIAGEN announces expansion of Supervisory Board&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T20:53:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"QIAGEN announces expansion of Supervisory Board\",\"datePublished\":\"2023-04-20T20:53:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/\"},\"wordCount\":744,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/\",\"name\":\"QIAGEN announces expansion of Supervisory Board - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=\",\"datePublished\":\"2023-04-20T20:53:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-announces-expansion-of-supervisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"QIAGEN announces expansion of Supervisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"QIAGEN announces expansion of Supervisory Board - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/","og_locale":"en_US","og_type":"article","og_title":"QIAGEN announces expansion of Supervisory Board - Market Newsdesk","og_description":"Steve Rusckowski has joined Supervisory Board and will stand for election at Annual General Meeting in June 2023 Venlo, the Netherlands, April 20, 2023 (GLOBE NEWSWIRE) &#8212; QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Steve Rusckowski, an internationally recognized healthcare industry executive and former Chairman, President and CEO of Quest Diagnostics, has joined the Supervisory Board as a new member and will stand for election at the next Annual General Meeting scheduled for June 22, 2023. \u201cIt is with great pleasure that we welcome Steve Rusckowski to our Supervisory Board. He has had a remarkable career in the healthcare industry and a proven track record as the leader of one of the world\u2019s most important diagnostics companies. &hellip; Continue reading \"QIAGEN announces expansion of Supervisory Board\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-20T20:53:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"QIAGEN announces expansion of Supervisory Board","datePublished":"2023-04-20T20:53:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/"},"wordCount":744,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/","name":"QIAGEN announces expansion of Supervisory Board - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=","datePublished":"2023-04-20T20:53:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjAxNSM1NTM3NzI2IzIwMTk2MDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-announces-expansion-of-supervisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"QIAGEN announces expansion of Supervisory Board"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749795"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749795\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}